In humans, intravenous infusion of a somatostatin analog, octreotide, 30 min prior to carbohydrate meal (Hycal) significantly impairs insulin, GLP-1, and GIP secretion in both lean and obese women, yet post-heparin LPL activity (contributions from adipose, skeletal and cardiac tissue) is unchanged 1.5 h post-peak insulin in lean and obese women (Ranganath et al., 1999)
These GLP-1 receptor agonist weight loss injections, originally developed for managing type 2 diabetes, not only promote significant weight loss but may also help with countless obesity-related health risks including pre-diabetes, heart disease, sleep apnea, and more
For any other information or to book your appointment for your IM Vitamin B12 shot, you can message us here or leave a comment
Without a scale, it's easy to underestimate your intake, which can derail your progress